BH60 Automated Glycohemoglobin Analyzer
Diabetes monitoring (HbA1c)
CommercialLaunched 2021
Key Facts
Indication
Diabetes monitoring (HbA1c)
Phase
Commercial
Status
Launched 2021
About BioHermes Bio & Medical Technology
Chinese diagnostics company focused on point-of-care HbA1c analyzers for diabetes management, with FDA-cleared products and global market presence.
View full company profileTherapeutic Areas
Other Diabetes monitoring (HbA1c) Drugs
| Drug | Company | Phase |
|---|---|---|
| A1cChek Pro Glycohemoglobin Analyzer | BioHermes Bio & Medical Technology | Commercial |